Hundreds of people with a rare and aggressive form of leukaemia will be able to access a CAR-T therapy developed by UK biotech Autolus after it was recommended for routine commissioning by the NHS.
This local AI quickly replaced Ollama on my Mac - here's why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results